Illumina Inc (NASDAQ:ILMN)

CAPS Rating: 4 out of 5

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.

Recs

0
Player Avatar HIGHG33K (71.79) Submitted: 7/9/2012 3:33:53 PM : Outperform Start Price: $40.63 ILMN Score: +47.49

A takeover target.

Featured Broker Partners


Advertisement